SC
TMO icon

Swan Capital’s Thermo Fisher Scientific TMO Stock Holding History

Swan Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.51K Buy
9
+7
+350% +$3.36K ﹤0.01% 281
2026
Q1 		$983 Hold
2
– – ﹤0.01% 441
2025
Q4 		$1.16K Hold
2
– – ﹤0.01% 390
2025
Q3 		$970 Sell
2
-1
-33% -$465 ﹤0.01% 394
2025
Q2 		$1.22K Buy
+3
New +$1.25K ﹤0.01% 362

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Swan Capital's TMO Position: Q2 2026 in Review

Swan Capital increased its Thermo Fisher Scientific (TMO) stake by 350% in Q2 2026, buying an estimated $3.36K and bringing the position to 9 shares worth $4.51K. The position accounts for ﹤0.01% of the portfolio, ranked #281.

Swan Capital first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Swan Capital held 9 shares of Thermo Fisher Scientific worth $4.51K as of Q2 2026.
  • Swan Capital bought 7 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.36K.
  • Thermo Fisher Scientific made up ﹤0.01% of Swan Capital's portfolio in Q2 2026, its #281 holding.
  • Swan Capital first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.